Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Clinical trial NCT03994627 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03994627
- Sponsor
- Eli Lilly and Company
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.